Global Pharmaceutical Intermediates Market, By Intermediate Type, By Application, By End User, By Geography

Description

The pharmaceutical intermediates market is estimated to be valued at USD 43.67 Bn in 2024 and is expected to reach USD 75.12 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 43.67 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.10%	2030/2031 Value Projection:	US$ 75.12 Bn

Global Pharmaceutical Intermediates Market Share (%), By Region, 2024

Global Pharmaceutical Intermediates Market - IMG1

The pharmaceutical intermediates market has been witnessing significant growth over the past few years. Pharmaceutical intermediates are chemical compounds produced during the various steps of pharmaceutical drug synthesis. They help in efficiently manufacturing drugs in large quantities with minimum resources. Rising prevalence of chronic diseases along with increasing R&D investments by pharmaceutical companies are fueling the demand for intermediates. Additionally, the growing geriatric population worldwide prone to chronic medical conditions is positively influencing the market growth. However, strict regulatory frameworks for the approval of new intermediates and high capital requirement for setting up manufacturing facilities are some challenges restraining the market growth. Overall, the widespread use of intermediates in streamlining drug production processes indicates huge opportunities for market expansion in the coming years.

Market Dynamics:

The global pharmaceutical intermediates market is primarily driven by the growing incidence of lifestyle-induced chronic diseases like diabetes, cancer, cardiovascular disorders, etc. Favorable government policies supporting local drug manufacturing is another key factor pushing the market growth. On the other hand, factors like high R&D costs associated with developing novel intermediates and lengthy approval times from regulatory bodies are slowing the market progress. Also, intense competition among established players poses major challenge to new entrants. However, rising pharmaceutical outsourcing trends from developing countries present lucrative opportunities for market players. Continued technological innovations to develop safe and eco-friendly intermediates will further support the market expansion over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical intermediates market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical intermediates market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Evonik, Borregaard AS, Sudarshan Pharma, A.R. Life Science, Actylis, Saurav Chemicals Ltd., Lianhetech, Midas Pharma GmbH, Sanofi , BASF SE, Chiracon GmbH, Lonza, Chemcon Speciality Chemicals Limited., Modepro India Pvt. Ltd., Lifechem Pharma, Sarex, and LANXESS.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global pharmaceutical intermediates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical intermediates market.

Detailed Segmentation:

Intermediate Type:
- Bulk Intermediate
- Chemical Intermediate
Application:
- Anti-Infective Drugs
- Analgesics
- Antidiabetic Drugs
- Cardiovascular Drugs
- Antimicrobial Drugs
- Anti-inflammatory Drugs
- Others
End User:
- Biopharmaceutical Companies
- CMO
- CRO
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Evonik
- Borregaard AS
- Sudarshan Pharma
- R. Life Science
- Actylis
- Saurav Chemicals Ltd.
- Lianhetech
- Midas Pharma GmbH
- Sanofi
- BASF SE
- Chiracon GmbH
- Lonza
- Chemcon Speciality Chemicals Limited.
- Modepro India Pvt. Ltd.
- Lifechem Pharma
- Sarex
- LANXESS

Product Code: CMI6740

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Intermediate Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending, by Country
Manufacturing Capacities
Distributors Landscape

4. Global Pharmaceutical Intermediates Market, By Intermediate Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Bulk Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chemical Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Pharmaceutical Intermediates Market, By Application, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Anti-Infective Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antidiabetic Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cardiovascular Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antimicrobial Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Anti-inflammatory Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Pharmaceutical Intermediates Market, By End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CMO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CRO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Pharmaceutical Intermediates Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Company Profiles - Global Pharmaceutical Intermediates Market

Evonik
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Borregaard AS
Sudarshan Pharma
A.R. Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS

9. References and Research Methodology

References
Research Methodology
About us and Sales Contact